Skip to main content

Advertisement

Fig. 2 | Parasites & Vectors

Fig. 2

From: A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection

Fig. 2

Serum concentration-time curves of SLN-PZQ and or market PZQ at a single dose of 500 mg/kg. Abbreviations: (N) M-PZQ, serum concentration of market praziquantel in normal mice; (Inf) M-PZQ, serum concentration of market praziquantel in S. mansoni-infected mice; (N) SLN-PZQ, serum concentration of solid lipid nanoparticle praziquantel in normal mice; (Inf) SLN-PZQ, serum concentration of solid lipid nanoparticle praziquantel in S. mansoni-infected mice

Back to article page